1. Home
  2. OSS vs BIVI Comparison

OSS vs BIVI Comparison

Compare OSS & BIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo One Stop Systems Inc.

OSS

One Stop Systems Inc.

HOLD

Current Price

$7.72

Market Cap

197.3M

Sector

Technology

ML Signal

HOLD

Logo BioVie Inc.

BIVI

BioVie Inc.

HOLD

Current Price

$1.36

Market Cap

8.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSS
BIVI
Founded
1998
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.3M
8.5M
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
OSS
BIVI
Price
$7.72
$1.36
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
1.5M
62.4K
Earning Date
03-18-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
133.85
N/A
EPS
0.22
N/A
Revenue
$37,027,382.00
N/A
Revenue This Year
$13.57
N/A
Revenue Next Year
$23.40
N/A
P/E Ratio
$38.82
N/A
Revenue Growth
34.46
N/A
52 Week Low
$1.85
$0.62
52 Week High
$12.75
$9.09

Technical Indicators

Market Signals
Indicator
OSS
BIVI
Relative Strength Index (RSI) 38.13 53.27
Support Level $4.78 $1.21
Resistance Level $12.48 $1.52
Average True Range (ATR) 0.95 0.11
MACD -0.21 -0.01
Stochastic Oscillator 1.87 56.25

Price Performance

Historical Comparison
OSS
BIVI

About OSS One Stop Systems Inc.

One Stop Systems Inc designs, manufactures, and markets specialized rugged high-performance compute ("HPC"), high-speed switch fabrics, and storage systems, which are designed to target edge applications for artificial intelligence ("AI") / machine learning ("ML"), sensor processing, sensor fusion, and autonomy. The company operates in two reportable segments; OSS designs and manufactures high-performance customized computers and flash arrays, in-flight entertainment & connectivity. Bressner operates as a system integrator with standard and custom all-in-one hardware systems and components for many kinds of industrial environments. The company generates the majority of its revenue from the Bressner segment.

About BIVI BioVie Inc.

BioVie Inc is a clinical-stage company developing drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is conducting a potentially pivotal Phase 3 randomized, double-blind, placebo-controlled, parallel-group, multicenter study to evaluate NE3107 in patients who have mild to moderate Alzheimer's disease. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism.

Share on Social Networks: